David Roife

1.1k total citations
25 papers, 827 citations indexed

About

David Roife is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, David Roife has authored 25 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in David Roife's work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Cells and Metastasis (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). David Roife is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cancer Cells and Metastasis (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). David Roife collaborates with scholars based in United States, Japan and France. David Roife's co-authors include Jason B. Fleming, Richard H. Gomer, Ya’an Kang, Darrell Pilling, Xinqun Li, Min Wang, Elizabeth L. Travis, Michael Pratt, Bingbing Dai and Rei Suzuki and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

David Roife

25 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Roife United States 16 274 267 167 156 127 25 827
Masayuki Nagahashi Japan 14 503 1.8× 394 1.5× 155 0.9× 178 1.1× 287 2.3× 27 1.0k
Dalibor Valík Czechia 18 474 1.7× 300 1.1× 155 0.9× 108 0.7× 212 1.7× 73 1.1k
Sharon B. Sams United States 17 382 1.4× 514 1.9× 134 0.8× 208 1.3× 229 1.8× 40 1.0k
Gennaro Gadaleta‐Caldarola Italy 19 312 1.1× 406 1.5× 106 0.6× 261 1.7× 189 1.5× 51 1.0k
Zhixing Guo China 14 459 1.7× 350 1.3× 110 0.7× 166 1.1× 162 1.3× 37 1.1k
Siu W. Lam Netherlands 12 251 0.9× 252 0.9× 150 0.9× 102 0.7× 128 1.0× 19 753
Lingya Pan China 22 494 1.8× 228 0.9× 84 0.5× 134 0.9× 236 1.9× 108 1.4k
Gregory Dyson United States 20 577 2.1× 304 1.1× 97 0.6× 142 0.9× 326 2.6× 74 1.1k
Ernesta Cavalcanti Italy 17 288 1.1× 580 2.2× 246 1.5× 126 0.8× 137 1.1× 52 994

Countries citing papers authored by David Roife

Since Specialization
Citations

This map shows the geographic impact of David Roife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Roife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Roife more than expected).

Fields of papers citing papers by David Roife

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Roife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Roife. The network helps show where David Roife may publish in the future.

Co-authorship network of co-authors of David Roife

This figure shows the co-authorship network connecting the top 25 collaborators of David Roife. A scholar is included among the top collaborators of David Roife based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Roife. David Roife is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Bingbing, Jithesh J. Augustine, Ya’an Kang, et al.. (2021). Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. Cell Death and Disease. 12(7). 693–693. 7 indexed citations
2.
Roife, David, Jason B. Fleming, & Richard H. Gomer. (2020). Fibrocytes in the Tumor Microenvironment. Advances in experimental medicine and biology. 1224. 79–85. 10 indexed citations
3.
Allenson, Kelvin, David Roife, Lillian S. Kao, Tien C. Ko, & Curtis J. Wray. (2020). Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index. Journal of Gastrointestinal Oncology. 11(2). 291–297. 8 indexed citations
4.
5.
Roife, David, Bhaswati Sarcar, & Jason B. Fleming. (2020). Stellate Cells in the Tumor Microenvironment. Advances in experimental medicine and biology. 1263. 67–84. 11 indexed citations
6.
Dai, Bingbing, David Roife, Ya’an Kang, et al.. (2017). Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(4). 662–670. 17 indexed citations
7.
Roife, David, Ya’an Kang, Li Wang, et al.. (2017). Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy. Surgery. 161(5). 1246–1254. 18 indexed citations
8.
Kang, Ya’an, David Roife, Michael Pratt, et al.. (2017). Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Oncogene. 36(38). 5432–5438. 35 indexed citations
9.
Banki, Farzaneh, et al.. (2017). Laparoscopic Reoperative Antireflux Surgery Is More Cost-Effective than Open Approach. Journal of the American College of Surgeons. 225(2). 235–242. 8 indexed citations
10.
Kang, Ya’an, David Roife, Yeon‐Ju Lee, et al.. (2016). Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clinical Cancer Research. 22(19). 4934–4946. 29 indexed citations
11.
Roife, David, Bingbing Dai, Ya’an Kang, et al.. (2016). Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 22(24). 6021–6030. 46 indexed citations
12.
Alawadi, Zeinab M., et al.. (2016). Do Socioeconomic Factors and Race Determine the Likelihood of Breast-Conserving Surgery?. Clinical Breast Cancer. 16(4). e93–e97. 21 indexed citations
13.
Banki, Farzaneh, et al.. (2016). Laparoscopic reoperative antireflux surgery: A safe procedure with high patient satisfaction and low morbidity. The American Journal of Surgery. 212(6). 1115–1120. 14 indexed citations
14.
Roife, David, Bing Dai, Ya’an Kang, et al.. (2016). Auranofin to prevent progression of pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 34(4_suppl). 236–236. 7 indexed citations
15.
Li, Xinqun, Ya’an Kang, Xavier Chopin‐Laly, et al.. (2014). Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery. Clinical Cancer Research. 20(24). 6529–6540. 69 indexed citations
16.
Kang, Ya’an, Jianhua Ling, Rei Suzuki, et al.. (2014). SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium. PLoS ONE. 9(9). e107948–e107948. 30 indexed citations
17.
Kang, Ya’an, Ran Zhang, Rei Suzuki, et al.. (2014). Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype. Laboratory Investigation. 95(2). 207–222. 35 indexed citations
18.
Roife, David, et al.. (2013). Serum amyloid P inhibits granulocyte adhesion. PubMed. 6(1). 2–2. 30 indexed citations
19.
Gomer, Richard H., et al.. (2009). A serum amyloid P‐binding hydrogel speeds healing of partial thickness wounds in pigs. Wound Repair and Regeneration. 17(3). 397–404. 15 indexed citations
20.
Pilling, Darrell, et al.. (2007). Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P. The Journal of Immunology. 179(6). 4035–4044. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Nagahashi Breakdown of academic impact, for papers by Dalibor Valík Breakdown of academic impact, for papers by Sharon B. Sams Breakdown of academic impact, for papers by Gennaro Gadaleta‐Caldarola Breakdown of academic impact, for papers by Zhixing Guo Breakdown of academic impact, for papers by Siu W. Lam Breakdown of academic impact, for papers by Lingya Pan Breakdown of academic impact, for papers by Gregory Dyson Breakdown of academic impact, for papers by Ernesta Cavalcanti
Rankless by CCL
2026